what is glp-1 agonist therapy Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Agonists - FAQ —

Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg

Check with your health insurance or your employer health program to see if it is covered

This is a huge market

Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)

If you're on medications or managing a health condition, check with your provider before use